And yes, the Youtube channel Bloomberg Television has again the right to an article on Croblanc today, and at the same time it is quite logical considering the passion that our community puts every time a new video is available on the internet. We think you'll find this video interesting, so we decided to make this post today.
Not to hide anything, when we saw that the Youtube channel Bloomberg Television had published a new video called Why Biogen Agreed to Acquire Reata for $7.3 Billion, we did not hesitate one second to share it with you so that you can discover it!
The video is doing a very good start since it was uploaded on the Youtube channel of Bloomberg Television and it could well end up in trend if the scores remain at these levels. However, we should not get too excited and wait a few days to see if this good start is confirmed with a buzz on the duration.
Do you have a question to share with the author of this video? Or maybe you just have a message to share. To talk to a youtuber (that's how we call content creators on the Youtube platform], go directly to his channel, in the "About" section more precisely. If he doesn't answer you, try again on his social networks: Facebook, Instagram or Twitter for example!
We hope you have enjoyed this article, and that the video Why Biogen Agreed to Acquire Reata for $7.3 Billion has met all your expectations. We hope to see you soon on Croblanc, until then you will be able to watch other videos of Bloomberg Television by searching a little on our dedicated platform. If you have already done the trick, go to Youtube, the content is almost infinite!
We will meet again very soon for a new article on Croblanc, see you soon!
For your information, you can find below the description of the video Why Biogen Agreed to Acquire Reata for $7.3 Billion published by the Youtube channel Bloomberg Television:
Biogen agreed to acquire Reata Pharmaceuticals for $7.3 billion, including debt, to expand its rare disease treatments. Michelle Davis reports on "Bloomberg Markets."
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en